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Summary
Superantigen
bound to major histocompatibility complex (MHC) products have been shown
to
stimulate T cells in a V(3-specific manner
.
Mouse T cells bearing V08
.1
usually respond to
the
self superantigen, Mls-1a, whereas T cells bearing VR8
.2a
do not
.
Previously, using site-
directed
mutational analysis, we identified the residues of natural variants ofT cell receptor (TCR)
V08.2
that conferred Mls-1' reactivity
.
These residues are predicted to lie on a (3-pleated sheet
of
theTCRVa element, well away from the expected binding site for antigen andMHC proteins
.
This
study was undertaken to determine the effect of glycosylation on this (3-pleated sheet on
Mls-1'
reactivity and to map the extent of the interaction site on V08
.2
for Mls-1a
.
A
panel ofT cell hybridomas expressing mutant V08
.2
elements were tested for their responses
to
Mls-1', as well as to peptides derived from the conventional protein antigen, chicken
ovalbumin .
Here we demonstrate that first, Winked carbohydrate on the lateral surface ofVa
blocks
the interaction of the TCR V(3 with the self superantigen, Mls-1', but has no effect on
the
TCR interaction with peptide antigen and MHC, second, that the interaction site for Mls-1'
extends
over the surface of the solvent-exposed /3-pleated sheet on the side of the TCR, and
third,
that mutations which affect both superantigen and peptide antigen reactivity lie at the
beginning
of the first complementarity determining region of VA consistent with models of
the
trimolecular complex of TCR-peptide-MHC
.
In
general, all five variable elements (Va, Joe, VO DO, and
JO)
ofTCRa/(3 are involved in recognition of peptide
fragments
of protein antigens presented byMHC molecules
(1,
2)
.
Recently, however, there have been several reports of
T
cell responses to certain antigens which are dictated pri-
marily
by the Vii element oftheTCR (3-15)
.
We have coined
the
term "superantigen" to describe these antigens (13)
.
There
are
two groups of superantigens
:
the self superantigens, en-
dogenous
murine products including the Mls determinants
and
a number of B cell-specific products, and the foreign
superantigens,
which encompass a variety of bacterial prod-
ucts
produced by Staphylococci, Streptococci, and Mycoplasma
(reviewed
in reference 16)
.
The superantigens are character-
ized
by their ability to form complexes with a variety of al-
lelic
forms of class II MHC molecules and to stimulate T
cells
at very high frequency on the basis of the V(3 element
of
their TCRs
.
We
previously reported the identification of the region of
the
TCR /3 chain that interacts with one of the self superan-
tigens,
Mls-la (17)
.
Variant V08
.2
elements, V08
.2b,
and
V08.2c
(Table 1), were identified in populations of wild mice
and
T cells bearing them were shown to be Mls-1, reactive
(18).
Site directed mutational analysis oftheV08
.2a
gene from
a
non-Mls-reactive T cell hybridoma allowed identification
of
the variant residues expressed by the wild mice that were
important
for conferring Mls-la reactivity
.
Since there is as
yet
no three dimensional structure available for the TCR,
we
interpreted the mutations we had generated using a model
for
TCR structure based on that of immunoglobulins (19)
.
The
variant residues carried by the wild mouse V08
.2
ele-
ments
that contributed to the interaction with Mls-1' are
predicted
to lie on a solvent-exposed a-pleated sheet ofVO
at
a distance away from the CDRs that are thought to bind
the
complex of peptide andMHC
.
Fig
.
1 shows a schematic
representation
ofthis a-pleated sheet ofV08
.2a
viewed from
the
side of the TCR
.
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173 May 1991 1183-1192The conventional V#8.2a element has two potential sites
for N-linked glycosylation andboth ofthese sites were affected
by the variant residues whichled to Mls-1' reactivity of wild
mouseT cells bearing the V08.2b and V08.2c alleles. The
first aim of thepresent study was to determine whether car-
bohydrate on the solvent-exposed a-pleated sheet on the side
ofV08.2a might mask a V/3 interaction site for Mls-1' . Our
data show that exposure of the /3-pleated sheet by loss of at
least one glycosylation site is necessary, but not always
sufficient, for Mls-1' interaction . The second aim of this
study was to determine which other residues on the surface
of the 0-pleated sheet contribute significantly to the Mls-1'
interaction site . We found these residues to be distributed
over the whole area of the exposed 0-pleated sheet .
Materials and Methods
Mice.
￿
All mice were purchased from'TheJackson Laboratory
Bar Harbor, ME .
Cell Lines.
￿
Transfected T cell hybridomas expressing mutant
Va8.2 elements were generated as previously described (17) . All
theTCRmutants included in this study areshown in Table 1 . DO-
11.10.3 andDO-11.10.7 were used as transfection recipients.They
are TCR chain loss-variants of the chicken ovalbumin specific T
cell hybrid DO-11.10 (20, 21) .
Analysis ofT Cell Markers.
￿
Expression of receptors on T cell
hybridoma transfectantswas assessedby immunofluorescent staining
using a collection of anti-V#8 antibodies ; antiVO8.1+8.2+8.3,
F23.1 (22), antiV08.1+8.2, KJ16 (23), antiV08.2a, F23.2 (22),
and the antibody specific for the idiotype of DO-11.10, KJ1 (24) .
The transfectants were also analyzed for their expression ofCD4
using GK1.5 (25) . In all cases biotinylated antibodies were used
in conjunction with phycoerythrin-coupled avidin (Tago Inc.,
Burlingame, CA) as previously described (13).
Stimulation Assays.
￿
Transfected T cell hybridomas were screened
for Mls-1' reactivity by culturing 105 hybrid cells with 106 spleen
cells from CBA/J (Mls-1'), (CBA/J x CBA/CaJ) Fl (Mls-1'1) or
CBA/CaJ (Mls-111) . Responses of thehybridomas to various doses
of chicken ovalbumin peptide (cOVA)' 327-339 were assessed by
culturing 105 hybrid T cells with 106 spleen cells from BALB/c
(H-2d) or C57BL/10 (H-2b) . Stimulation by solid phase antiTCR
mAbs provided controls for responsiveness of the hybrids . Micro-
titer wellswere coated with 100Ag/ml affinity-purified goat anti-rat
IgG (H + L) (Jackson ImmunoResearch Inc., Avondale, PA) or
40 hg/ml proteinA(Sigma ChemicalCo., St . Louis, MO). Subse-
quently, the wells were washed thoroughly and incubated with
KJ16 orGM5.777-containing supernatants. After further washing
of the wells, 10 5 T cell hybridswere cultured per well . After 24 h
the contents of the wellswere assayed for lymphokine production
using the HT-2 cell line (26) . Survival ofHT -2 cells was assessed
using 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyltetrazohwn bromide
(MTT) (Sigma Chemical Co .) (27) .
Production oftheGM5.777MonoclonalAntibody.
￿
TCRfrom the
T cell hybrid 2HB51.8 (28) was purified using an immunoaffinity
column bearing a mAb (H28-710) specific forCa (29) . 2HB51.8
expresses four TCR chains, Val- and VSl-bearing chains from
the fusion partner BW5147, as well as Va10- and V05.1-bearing
1 Abbreviations used in this paper cOVA, chicken ovalbumin ; SE, Staphy-
lococcal enterotoxins.
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chains. Armenian hamsters were immunized five timeswith purified
receptor. B cell hybridomas were produced by fusing spleen cells
from one of the hamsters with the variant myeloma line
P3X63AG8.653/3 . The primary B cell hybrid supernatants were
screened for binding to 2HB5.18 in an ELISA and the secondary
screen employed staining thesameT cell hybrid with the antibody-
containing supernatants followed by FITC-coupled proteinA(Sigma
Chemical Co.) . One mAb, GM5.777, stained 2HB51.8 and was
cloned for further use.
To determine the specificity ofGM5.777, the antibody wasused
to stain a panel of T cell hybrids expressing different TCRs, de-
rived from C57BL/10 (30) . GM5.777 reacted with the majority
of hybrids generated with BW5147 (22/25), whereas it did not
react with any of those generated using an a chain loss variant
ofBW5147 (0/29) (31), suggesting that the antibody maybe binding
to an epitope present on theBW-derived Val-bearing chain or to
a combinatorial determinant generatedby the Veil andVol chains
contributed by BW Since GM5.777 did not bind significant
numbers of peripheral T cells from AKRor C57BL/10 (data not
shown), it is unlikely that the antibody is specific for Val elements.
Surface Labeling ofCells.
￿
Cell surface iodination oftransfected
T cell hybrids was performed by the chemical reaction catalyzed
by Iodogen (Pierce ChemicalCo., Rockford, IL) as previously de-
scribed (32) . Cell lysateswere subsequently prepared by detergent
lysis in 1% NP-40 (32) and debris was removedby centrifugation
at 12,000 g for 20 min.
Immunoprecipitation .
￿
To immunoprecipitate individualaanda
chains of the TCR, the cell lysates were subjected to reduction
and alkylation . TheNP-40lysateswere reducedwith 0.05M2-ME
for 1 hat4°Cand subsequently alkylated with 0.15M iodoaceta-
mide at pH 8, for 1 h. Under these conditions immunoprecipita-
tion of the lysate with anti-O chain reagents results in the precipi-
tation of fl chains only (RT Kubo, unpublished observations) .
N-Glycanase Treatment. Immunoprecipitates were washed in
0.1M sodium phosphate buffer, pH 8.6, and were resuspended in
this buffer containing 0.5% SDS, pH 8.6, and boiled for 3 min.
After centrifugation the supernatant was removedand divided into
two samples. The samples were adjusted to 1% NP-40 and 6 JAI
50%glycerol/2.5mM EDTA, with or without 1.5 U N-glycanase
(Genzyme, Boston,MA), were added, as previouslydescribed (33) .
After overnight incubation at 37°C, an equal volume of2x Laemmli
sample buffer (34) was added to the samples before electrophoretic
analysis on 11% SDSpolyacrylamide gels under reducing conditions .
Results
In these studies on the effects of amino acid substitutions
in V(3 on the specificity ofT cells bearinga particular T cell
receptor, we chose to use derivatives of theTcell hybridoma
DO-11.10 . DO-11.10wascreatedby fusion ofaTcell specific
for cOVA and IAd with the thymoma BW5147 (20) . DO-
11.10 reacts with c0VA/IAd, weakly with IAb and
cOVA/IAb anddoes not react with WS-la. It expressesTCR
chains bearing Va13 and V#8.2a, derived from the normal
T cell parent, andVatandVOL derivedfromBW5147 . Two
derivatives were used in these experiments, DO-11.10.3, which
has lost the gene encoding theVf8.2a-bearing (3 chain, and
DO-11.10.7, which has lost this a chain gene and the gene
encoding the Va13-bearing a chain (21) . The products of
0 chain genes transfected intoDO-11.10.3 maytherefore pair
with either of thetwoendogenousachains, whileproducts
Analysis of the Interaction Site for Mls-1' On T Cell Receptor V(3N designates a potential N-linked glycosylation site .
(+) A weak response to CBA/J spleen cells .
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of the # chain genes transfected into DO-11.10.7 can only
pair with theBWderived cx chain. These derivatives were
transfected with genes encoding a chains with various mu-
tations in V08.2 (Table 1) and the transfectants were exam-
ined for the properties and specificities of the TCRs thus
generated .
Carbohydrate on Va8.2 Elements Blocks the Interaction ofTCRs
with Mls-1°. We have previously reported a number ofmu-
tations that revealed amino acids important for conferring
Mls-1' reactivity . The mutation 22N-D or the pair ofmu-
tations 70E-->K/71N-E conferred Mls-1' reactivity to the
otherwise non-Mls-1'-reactive, V08 .2a-bearing, T cell hy-
brid, DO-11.10 (17) . Both mutations 22N-D and 71N-E
destroyed potential glycosylation siteson theVf8.2a element
expressed by laboratory inbred mouse strains. To address
whether glycosylation at one or both of these sites blocks
a potential binding site for Mls-1' on V#8.2a we generated
a panel of transfectants expressing mutant V08.2 elements
in which the potential glycosylation sites were destroyed. The
consensus tripeptide sequence for an Winked glycosylation
site is NXS/T (where X is any amino acid) : thus to prevent
glycosylation these sites were altered byN-Q mutation or,
alternatively, by S-A or T-"A mutation.
To determine whether the potential glycosylation sites on
theVf8.2 element were indeed glycosylated, the TCR chains
from 1125 surface-labeled hybrids expressing transfected nor-
mal or mutant (3 genes were analyzed . The cells were surface
labeled and lysed as described in the Materials and Methods .
Reduction and alkylation of the lysates resulted in the dis-
sociation ofthe cx and 0 chains of theTCR such that subse-
quent immunoprecipitation using mAbs specific for the (3
chain resulted in onlya chains in the immunoprecipitate (RT
Kubo, unpublished observation) .
The results ofthe F23.1 immunoprecipitation for four trans-
fected hybrids are shown in Fig. 2 A . The mutant a chains
22N--"Q and 71N-Q ran with slightly higher mol wt than
the mutanta chain22N-D/70E-K/71N-E (compare lanes
2 and 3 with 4) that had no potentialVO glycosylation sites,
indicating that N-linked carbohydrate could be present on
residues 71 or 22 . If both of the potential glycosylation sites
on the V08.2a element were glycosylated, then the molec-
ular mass of the wild type V,38.2a-bearing /3 chain would
be expected to be greater than that of mutant,l3 chains22N--Q
or 71N-+Q, however this was not seen to be the case (com-
pare lane 1 with lanes 2 and 3, Fig. 2 A) . The V08.2a 0
chain ran as a broad band with a molecular mass of about
Table 1 . V88.2 Mutants and Summary of Their Reactivity to Mls-1"
Amino acids mutated
Mls-1'
Mutation VO 16 17 18 20 22 24 51 65 70 71 72 73 reactivity
Wild type 8.2a K V T S N T D S E N F S
22N-D 8.2b D
16K-A/22N-D A D
16K-N/22N-D N D
17V-S/18T-V/22N-"D S V D
18T-N/22N-"D N D
22N-D/24T-Y D Y
22N-Q Q
24T-A A
22N-D/70E-"K/71N~E D K E +++
22N-D/51D-"G/70E-K/71N-E 8.2c D G K E +++
70E-K/71N-E K E ++
70E-K/71N-E/65S~V V K E ++
70E-K/71N-"E/72F-"S K E S ++
70E-K/71N-E/73S-I K E I ++
70E-K K
71N-E E
71N-Q Q
73S-A A -
70E-"K/73S-A K - - A +30
15
050
80
20
5
75
70
0~© © 0
0
© 0
0
0
Peptide Antigen +MHC Binding Site
60
Figure 1 .
￿
Schematic representation of the view from the side of the
TCR VJ38.2a element .The schematic is adapted from the model proposed
by Chothia et al . (19) . Mutations at these positions (0) disrupt TCR-
class II interactions, ([:]) affect TCR-Mls-1' interactions and (0) are not
critical for TCR-Mls-1' interactions . Shaded squares designate glycosyla-
tion sites .
43 kD . It is possible that both potential sites on V(38.2a are
not always glycosylated on each TCR molecule .
After N-glycanase treatment the /3 chains from all four
hybrids ranwith the same molecular mass of ti32 kD (lanes
S-8), indicating that themutations had not affected the mo-
bility of the polypeptide chains. The drop in molecularmass
from theuntreatedmutant (3 chain22N-+D/70E-K/71N-->
CE to the N-glycanase-treated bands (compare lane 4 with
lanes 5-8) is due to thepresence of three Winked carbohy-
date moieties on C/3 (35) .
Transfected hybridomas were matched for their levels of
expression of the mutant gene products using the antiidio-
Table 2,
￿
Response of Transfectants to Mls-la Expressing
Spleen Cells
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IL-2 production
DO-11 .10.3 DO-11.10.7
Transfectants
￿
(Val, Va13)
￿
(Val)
U/ml
V(38.2a
￿
-
￿
_
22N-"D
￿
>640
￿
-
22N-+Q
￿
40
￿
-
24T-A
￿
-
￿
-
71N-Q
￿
-
￿
-
73S-A
￿
-
￿
-
70E-K/71N-E >640 >640
-, 5 10 IL-2 U/ml .
All transfectants responded to KJ16-stimulation by generating X640 IL-2
U/ml .
typic antibody, KJl (24), which will detect Va13/V/38.2+
TCRs, or the anti V(38 antibody, F23.1 (22), whichwill de-
tect Va8.2+ a chains paired with any a chain. The DO-
11.10.3 transfectants all had high levels of the accessory mol-
ecule CD4 while the DO-11.10.7 transfectants all had low
levels of CD4 (17) . These transfectants were all tested for
their ability to respond to Mls-la presented by CBA/J spleen
cells . The DO-11.10.3 transfectant expressing mutation
22N--,Q (which prevented glycosylation at position 22)
responded to Mls-1' stimulation, while the DO-11.10.7
transfectant expressing the same mutation did not (Table 2) .
This result wasreminiscent ofour previous finding that DO-
11.10.3/22N-D was Mls-la reactive whilst DO-11.10.7/
22N-"D wasnot (17) . It is possible that thesemutant V(38.2
chains impart Mls-1' reactivity when they pair with the
WO-containingbut notwith the Vac1-containinga chain,
or alternatively, it may be that themutant receptor is sufficient
to confer Mls-la reactivity only in the presence of high levels
Figure 2 .
￿
Glycosylation ofVS8.2 elements . Transfectants were h25-surface labeled and lysed . Lysates were then reduced and alkylated, subsequently
TCRs were immunoprecipitated with F23.1, N-glycanase treated (+) or not (-), and were analyzed on 11% SDS-PAGE . (A) Glycosylation of V08.2
at positions 22 and 71 . Lanes 1 and 5, DO-11.10.7/VS8.2a; lanes 2 and 6, DO-11.10.7/22N-+Q ; lanes 3 and 7, DO-11.10.7/71N-+Q; lanes 4 and
8, DO-11.10.7/22N-+D/70E-"K/71N-+E . (B) Glycosylation of V/38 .2 at positions 16 or 18, and 71 . Lane 1, DO-11.10.3/22N-D ; lane 2, DO-
11.10.3/16K-+N/22N-D; lane 3, DO-11.10.3/18T-N/22N-D . Positions of mol wt markers are indicated and represent 45 kD (ovalbumin) and
30 kD (carbonic anhydrase) .Residues
￿
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Figure 3 .
￿
Response of DO-11.10.3 transfectants to Mls-1° and KJ16-
stimulation. IL2responses to CBA/J spleen cellswere assessed as described
in the Materials and Methods. < 10 ID2 U/ml were generated in response
to CBA/CaJ spleen cells . Mutations generated were variants of V08.2a .
Data shown are from a representative experiment . Transfectants were as-
sayed in at least three experiments .
of the accessory molecule CD4 . These results suggest that
prevention ofWinked glycosylation by mutations 22N-D
and22N-Q facilitates the interaction oftheV08.2-containing
TCR with Mls-la .
Neither of the transfectants expressing mutation 24T-A
responded to Mls-1a stimulation (Table 2), suggesting that
prevention of glycosylation at position 22 was alone insufficient
to confer Mls-reactivity and that 24T may be critical for this
reactivity . This possibility is addressed in more detail below.
Mutations 71N-Q and 73S-A also did not confer Mls-1a
reactivity (Table 2), demonstrating that prevention ofglycosy-
lation at position 71 was not sufficient to confer Mls-1' re-
activity onV08.2a . However, the analysis of more mutations
designed to determine exactly which residue(s) carried by the
variant Va8.2c allele contribute to its Mls-1a-reactivity sug-
gested that preventing glycosylation at position 71 was neces-
sary to unmask a potential interaction site for Mls-1a on
this V/3 .
In our previous studywe determined that the pair ofmu-
tations 70E-K/71N-E, carried by the variant V08.2c al-
lele, conferred Mls-1a reactivity upon both DO-11.10.3 and
DO-11.10.7 transfectants (17) . These mutations would, of
course, remove the Winked glycosylation site at position
71 and also introduce a charge change at position 70 . To test
which of these changes was required to confer Mls-1a-reac-
tivity on V08.2-bearing T cells we generated transfectants
expressing these mutations singly . In addition we also pro-
duced a transfectant which carried the pair of mutations
70E-K/73S-A . This V/3 element had the positively charged
lysine residue at position 70 and could not be glycosylated
at the adjacent asparagine residue since the consensus sequence
had been altered . The reactivity patterns for these hybrid-
omas are shown in Fig. 3 . Alone, neither of the charged
residues at 70 or 71 conferred Mls-1a reactivity, however mu-
tant 70E-"K/73S-A was reactive. This suggested that it
was necessary to prevent glycosylation at position 71 in order
to facilitate the interaction of Mls-la with the positively
charged lysine at position 70 . Further, the magnitude of the
response of mutant 70E-"K/73S-"A was reproducibly two-
fold lower than that of mutant 70E-K/71N->E, implying
1187
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that either 71E or 73Smay also facilitate the interaction with
Mls-1a .
Addition of Novel Glycosylation Sites in V08.2b Reduces
Mls-Id Reactivity . In light of our findings that Winked
carbohydrate at position 22 masked an interaction site for
Mls-1a on V08.2a, and that carbohydrate at position 71
prevented the interaction of the lysine residue carried by the
V08.2c allele with Mls-1a, we investigated the effect of in-
troducing new potential glycosylation sites elsewhere on the
solvent exposed a-pleated sheet ofV08.2b. DO-11.10 .3 trans-
fectants carrying the V08.2b allele (mutant 22N--,D), had
previously been generated and shown to be Mls-la reactive
(17) . Asparagine residues were substituted at positions 16 or
18 inV08.2b to introduce novel potential Winked glycosy-
lation sites . VO1 is glycosylated at position 18, whilst none
of the known VO elements have a potential glycosylation site
at position 16 .
SDS-PAGE analysis of F23 .1 immunoprecipitated /3 chains
from Ills surface-labeled transfectants bearing these mutant
R chains (Fig . 2 B) showed that mutant a chains 16K-
N/22N-"D and 18T->N/22N-D had higher molecular
masses than the V,68.2b-bearing (3 chain (mutant 22N-D)
(compare lanes 2 and 3 with lane 1), indicating that Winked
glycosylation did indeed occur at these novel sites.
These transfectants expressing mutant Va8.2 elements with
Winked carbohydrate present at position 71 and either posi-
tion 16 or position 18 were screened for Mls-1a reactivity,
using CBA/J spleen cells as stimulators . They showed di-
minished responses compared to mutant 22N-D (Fig. 4),
that is only glycosylated at position 71. To assess further this
reduction in Mls-1a responsiveness, in subsequent experi-
ments (CBA/J x CBA/CaJ)F1 spleen cells were also in-
cluded as stimulators . These stimulators were heterozygous
for Mls-1a and so are predicted to express half the level of
the stimulatory ligand . As shown in Fig. 4 the mutants with
novel glycosylation at positions 16 or 18 did not respond to
the F l spleen cells, confirming their reduced responsiveness
to Mls-1'.
In general theTCR mutations generated in this study did
not grossly alter the conformation of theTCR as judged by
the staining profiles with monoclonal antibodies F23.1 and
F23.2, which react withTCRs including allV#8s orV08.2a,
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Figure 4.
￿
Response of DO-11.10 .3 transkctants toNO-, Mls-1-/b and
KJ16-stimulation. Mutations generated were variants ofVf8.2b (mutant
22N-+D) . Sequence comparisons are made to V#8.2a . Data shown are
from a representative experiment. Transfectants were assayed for respon-
siveness to CBA/J in at least three experimentsand to (CBA/J x CBA/CaJ)
F1 in two experiments .respectively, and with the antiidiotypic antibody, KJl. It
should be noted, however, that mutation 16K--"N introduced
an additional Winked carbohydrate that caused the disrup-
tion of the binding site of another mAb, KJ16, specific for
V08.1 and Vl8.2s. KJ16 staining of the DO-11.10.3/
16K-->N/22N-D was undetectable (data not shown), but
this transfectant did respond to stimulation by KJ16 bound
to goat anti-rat Ig antibodies coated on culture wells (Fig.
4), suggesting that KJ16 didbind weakly to the mutant TCR .
The Mls-1° Interaction Site on V08.2 Extends Over the
Solvent-Exposed (3-Pleated Sheet On the Side ofthe TCR . To
determine the extent of the Mls-1a interaction site on the
solvent-exposed /3-pleated sheet on the side oftheTCR, mu-
tations were introduced into Mls-1a reactive Vf8.2 elements
whichwe had already generated. Transfectants expressing these
mutant Vos were then analyzed for Mls-reactivity . Loss of
Mls-11 reactivity would suggest that the mutated residues
were critical for the interaction with Mls-1a .
Instead of introducing random mutations in the V(3 ele-
ments, the available sequences ofV/3 elements were compared
for residues that are conserved among Mls-11 reactive Vas
but that are substituted in non-Mls-reactive V(3s. Three amino
acids stood out as being possible contributors to the Mls-1a
interaction site : 65S and 73S are present in all inbred mouse
strain Vls known to be Mls-11 reactive (Vf s 6, 7, 8.1, and
9) (4, 5, 9-12), and 7211 is present in Vos 6, 7, and 8.1 . Few
of the non-Mls-reactive Vf elements carry these residues at
these positions. We introduced mutations 65S-V, 7211-S,
or 73S-1 into the Vl8 .2 mutant element already known
to confer strong Mls-1a reactivity, mutant 70E-K/71N-E.
In thehope that theTCRwould maintain its gross structure
in spite of these additional mutations, the residues chosen
for substitution occurred in at least one other V(3 element.
For example, 72S is present in Vos 5.1, 5 .2, 11, 12, 13, and
15 . As shown in Fig . 5 none of these mutations reduced the
magnitudeofthe response toCBA/Jstimulator cells, demon-
strating that none of these residues appeared critical for the
Mls-11 reactivity of this particular Va8.2 element .
Residues 16K, 17V, 18T, and 24T are present in at least
two of the Mls-la-reactive Va elements, and therefore mu-
tations of these residues were introduced into the previously
Figure 5 .
￿
Response of DO-11.10 .3 transfectants to Mls-la and KJ16-
stimulation . Mutations generated werevariants ofmutant 70E-+K/71N-+E .
Sequence comparisons are made to V#8.2a. Data shown are from a repre-
sentative experiment . Transfectants were assayed inat least three experiments.
Figure 6 .
￿
Response of DO-11.10 .3 transfectants to Mls-la and KJ16-
stimulation . Mutations generated were variants of V08.26 (mutant
22N-D) . Sequence comparisons are made to V08.2a . Data shown are
from a representative experiment . Transfectants were assayed in at least
three experiments .
generated Mls-la-reactive V08.2b element (mutant
22N-D) . Mutation 16K-A had no effect on the Mls-la
reactivity oftheV08.2b element . However, mutation24T-Y,
or the pair of mutations 17V--"S/18T-V, were sufficient to
prevent Mls-11 reactivity (Fig. 6), indicating that 24T, and
17V, or 18T are critical for Mls-11 reactivity of V08.2b .
Thus, residues 17 or 18, and 24, as well as residues 22, 70,
and 71, contribute to Mls-la reactivity of V08.2-bearing
TCRs. Allthese residues lie on the solvent-exposed 0-pleated
sheet on the side of the TCR (Fig. 1) .
Mutations at Position 24 Alter Reactivity to Peptide Antigen-
'HC . There are three possible explanations fortheobserved
loss of Mls-1a reactivity due to mutations 24T-Y and
17V-S/18T-V First, the introduced mutations may have
grossly distorted thestructureofthe TCR, second, theymay
"have perturbed the interaction of the TCR with the MHC
class II molecule presenting the superantigen, Mls-la, or
third, they may have disrupted the interaction of theTCR
with Mls-1a .
Transfectants bearing these mutant V08.2 elements con-
tinued to stain with mAbs specific for V08.2 (1123.1, KJ16
and 1123.2) and the antiidiotypic antibody (KJ1) suggesting
0
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Figure 7 .
￿
Response ofDO-11.10.3 transfectants to chicken ovalbumin
peptide 327-339 . Peptide 327-339 was presented by (A) BALB/c spleen
cells (IAd) or by (B) C57BL/10SNJ spleen cells (IAb) . Results shown in
A andB were obtained in two separate experiments and are expressed rela-
tive to the maximal response of the transfectant carrying the wild type
DO-11.10 receptor (V08.2a) .that the TCR structure was not grossly distorted by the
24T-Y or 17V-S/18T-V mutations (data not shown) .
To assess the effect of these mutations upon the interac-
tion of theTCR with class II, the responses of the transfec-
tants to peptides of the conventional protein antigen COVA
were measured . There were no shifts in the dose response
curves for any of the mutant TCRs when the cOVA peptide
327-339 was presented by the IAd molecule (Fig. 7 A and
data not shown), suggesting that none ofthe mutations caused
major perturbation of the TCR interaction with this class
II molecule.
The measurement ofthe cross-reactive response ofthe trans-
fectants to cOVA peptides presented by IAb was hindered by
a weak background response in the absence of added cOVA
peptide. This response to IAb is contributed byTCRs com-
posed of the BWderived Vat-containing a chain and the
V08.2-containing /3 chain (21) . Inclusion of supernatant con-
taining mAb GM5.777 in the stimulation cultures blocked
this weak anti-IAb response (Table 3), confirming that the
antibody specificity was indeed for an epitope on the Val-
bearing a chain ofBW The use of this antibody facilitated
the assessment of the response of the transfectants to added
peptides, and indeed it may prove useful in dissecting the
reactivities ofother hybrids generated using theT cell fusion
partner, BW5147 .
Mutation 24T-Y caused at least a 100-fold shift in the
dose response curve to the cOVA peptide presented by IAb
(Fig. 7 B) . Transfectants expressing the 24T-A mutation,
that had been generated to investigate the role of glycosyla-
tion at position 22, also showed a diminished response (at
least 10-fold) to cOVA peptides presented by IAb (Fig. 7 B) .
These data suggest that mutations at position 24 perturb the
interaction of the TCR with the IAb molecule. The loss of
Mls-1a reactivity ofVa8.2b due to mutation 24T--"Y (Fig.
6) may therefore be due the disruption of the TCR/class II
interaction during the presentation of Mls-1a .
The paired mutations 17V-S/18T-V did not affect the
response to cOVA peptide presented by IAb (data not
shown), although they ablated the response to Mls-1a (Fig.
6) . This suggests that these mutations disrupt the interac-
tion of the TCR with Mls-1a, and not the interaction of the
TCR with MHC.
Table 3 .
￿
mAb GM5.777 Blocks the Response of DO-11.10 to IA 6
T cell receptor chains
T cell hybrid
￿
Val
￿
Vat
￿
Va13
￿
V08.2
￿
None
DO-11 .10 + + + +
DO-11 .10.3 + + + -
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Discussion
IL-2 production is expressed as U/ml ; -, 4 10 IL-2 U/ml.
Both T cell hybrids responded to GM5.777 stimulation by generating >640 IL-2 U/ml .
This paper concerns the structure of the trimolecular com-
plex formed between TCRs, class II MHC proteins and the
self superantigen, Mls-la . The structures of two of the com-
ponents ofthe complex, TCR and class II, havebeen modeled
on theknown structures of immunoglobulin and class I MHC,
respectively, and there is some evidence to support the con-
clusions thus drawn (19, 36-39) . Until very recently, themo-
lecular nature of Mls-12 was unknown . We have just shown,
however, that another mouse self superantigen is encoded by
a mouse mammary tumor virus (reference 40 andY Choi,
J.W . Kappler, andP Marrack, manuscript in preparation) and
it is likely that Mls-12 and other self superantigens will be
closely related. The complex studied in this paper is there-
fore formed between three proteins, two ofwhich are known
to be globular in nature.
Models of the TCR based on the structure ofimmuno-
globulin suggest that a solvent-exposed lateral surface ofthe
molecule is formed by a /3-pleated sheet made up of amino
acids ofVA This surface is predicted to be well away from
the residues in theCDRs, thought to contact antigenic pep-
tides and MHC, and is also well away from the contact re-
gion betweenVa andVf. Recent experiments have suggested
that it is this face of V)3 that binds superantigens (17, 41,
42) . We showed that mutant forms of Vf8.2 found in wild
mice probably engage Mls-12 with amino acids in this face
(17) . Variant forms of V017a isolated from wild mice by
Cazenave et al . (41) had lost the ability to react with amouse
superantigen plus IE, and one of the amino acids contributing
to the loss would also lie on the exposed /3-pleated sheet of
V/3, at position 71 by the numbering system used in this paper.
Other studies on receptor-ligand interactions indicate that
protein-protein interactions often occur over fairly large sur-
faces, with contact points formed betweenmany amino acids
on either protein (43, 44) . The experiments reported here
suggest that this is also true for the interaction betweenV08.2
and Mls-1a . For example, the presence of a lysine at position
70 . ofVa8.2 conferred Mls-la reactivity upon T cells bearing
it, providing an adjacent glycosylation site had also been de-
stroyed. Valine 17 and/or threonine 18 contributed to the
Mls-12 reactivity of this variant Vii and our results also in-
IL-2 production in response to IAb stimulation
Antibody present
KJI KJ16 GM5.777 KJ25
(anti-id) (anti-V08) (anti-BWa) (anti-V03)dicated that a glutaminic acid at position 71 or a serine res-
idue at 73 might also enhance binding of the same variant .
As illustrated in Fig. 1, these residues are predicted to lie quite
far apart on the solvent-exposed 0-pleated side of V16
The data also suggested that although V#8.2 and Mls-1a
could interact over a large area, it was not always essential
that residues over the whole area be engaged. In some mu-
tants one part of the f3-pleated sheet on the side of Vf3 con-
tributed to binding, in other mutants a different part of the
sheet was more important . T cells bearing V#8.2 that lack
the glycosylation site at position 22 could react with Mls-la
even though the 6 chain did not bear a lysine at position
70 . In the presence of glycosylation at position 22 however,
the absence of glycosylation at position 71 and a lysine at
position 70 were required for Mls-la reactivity.
It is likely that the mutations introduced at these posi-
tions affected Mls-1a reactivity because of direct effects on
the binding of Vf38.2 to Mls-1', rather than because of gross
distortions of theTCR . The products of all these mutations
continued to react normally with °OVA/IAd and moreover
also continued to react well with at least three offour mono-
clonal anti-V# antibodies.
Mutations in several of the amino acids which lie on the
solvent-exposed 0-pleated sheet of VA, that are conserved in
Vos known to react with Mls-1a (65S, 72F, and 73S), did
not affect reactivity in these experiments . Perhaps the changes
chosen were not disruptive enough : for example, no charge
changes were introduced by any of these mutations .
Among the most striking findings in these and our previous
studies were the discoveries that the interaction site on V0
for self superantigens lies on the side ofV0 and that it can
be masked by Winked carbohydrates . The finding that
Winked carbohydrate may conceal a potential binding site
is relatively novel . However, evolutionarily, such a strategy
offers the advantage that a relatively large binding site on
the side of Vf3 can be masked or revealed by a single amino
acid mutation. Interpretation of these experiments is ham-
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